Disposables Technology Trends, drivers & practices. Gordon Farquharson July 2017
|
|
- Megan Smith
- 5 years ago
- Views:
Transcription
1 Disposables Technology Trends, drivers & practices Gordon Farquharson July 2017
2 Agenda 1. Business drivers 2. Technical trends 3. Systems in practice 4. Comparison with fixed systems & justifications Slide 2 PharmOut 2017
3 The basic decision Slide 3 PharmOut 2017
4 Basis for analysis Paper reference: November 2008 BioPharm International paper "The environmental impact of disposable technologies Can disposables reduce your facility's environmental footprint? (Sinclair, Leveen, Monge, Lim and Cox) Process Cost Models Analyse the impact of a specific technology within a given process Disposables vs. stainless Technology performance can be modelled in computer programmes like BioSolve Impact on Cost of Goods Process throughput Impact on facility: utilities, waste streams, etc. Slide 4 PharmOut 2017
5 Challenges in Bio-pharma 1. Compared to chemical pharmaceuticals Drugs are complex products. Sophisticated manufacturing facilities. 2. Product development is expensive & slow 3. Products are expensive to make (on a per treatment basis) Especially current generation MABs 4. Production facilities have traditionally been very expensive and inflexible 5. Rapid response is often required Biodefense Epidemics (Pandemic flu) 6. Competition from Bio-similars Slide 5 PharmOut 2017
6 Manufacturing trends Trends Success rates & yields increased Titres have greatly increased Titre improvements continue & will reduce the volume of bioreactor capacity. Titres and Yields of Licensed Antibodies will gradually increase over time' There will be more Antibodies with smaller market penetration/sales and lower Product Mass (50-500kg) requirements'. Implications Plant size decreasing Need for more flexible facilities Disposable technologies will have greater application for commercial supply However Cost is an issue Maturity and supply chain security Slide 6 PharmOut 2017
7 Key challenges Business analysis When & where is it cost effective to implement disposable technologies into a given process. Impact on design logistics Need for better understanding of the possibilities Facilities that can be rapidly expanded with minimum effort. Environmental impact of disposables. Procurement and supply chain dependency. Slide 7 PharmOut 2017
8 Disposable Risk/Benefit Assessment Risks Nature Mitigation Technology maturity Economics Supplier and application dependent Depends on degree of novelty and extent of available competition Formal assessment Evaluate full life-cyle costs capital & operation Supplier dependency Available competition Design system to maximise choice. Validation The environment Dependent on the defined approach Extent and method of waste treatment Risk based approach to current industry practice Assess, mitigate impact, treat waste stream Slide 8 PharmOut 2017
9 Disposable Key positive effects Feature Effect Outcome Remove or reduce CIP & SIP requirements Faster product/batch change-over Ease of reconfiguration Reduce complex pipework. Reduce automation systems requirements. Reduced activity for washing, cleaning, and preparing reused equipment. Can set up new process trails easily. Can be developed and validated off-line. Reduced periodic qualification. De-couple building and process systems. Lass labour. Less water and energy. Less labour. Better utilisation. Supports lean manufacturing. Easily reconfigured in response to new products and improved yield as process matures. Note: Facility design has to be completely changed in concept = loose fit solution. Slide 9 PharmOut 2017
10 Result = Less complexity, smaller (1000 L scale) Slide 10 PharmOut 2017
11 Disposable examples Reactors & vessels Slide 11 PharmOut 2017
12 Disposable examples Connectors Slide 12 PharmOut 2017
13 Layout of a Complete Disposable Aseptic Processing mixer Disposable formulation, Filtration system Grade A Pump Slide 13 PharmOut 2017
14 Disposable Final Fill and Finish Acerta Dispensing System (Millipore) Novel patented disposable liquid dispensing Volumetric Fill - Gravity Driven Matches Conventional Filling Systems Fill Reproducibility: < 0.5% at 1.0 ml Set-up Time: 30 min. Fill Volume Range: 0.5 to 20 ml Fill Rates: up to 40 / minute per head at 1.0 ml All product contact parts are disposable The set-up is pre-assembled, integrity tested and gamma sterilized up to 45 kilograys Components are: Platinum-cured silicon and C-flex tubing LDPE reservoir Polycarbonate sight tubes and needles All materials are USP Class VI Slide 14 PharmOut 2017
15 Conclusions Biological medicines are very significant business going forward Pressure to reduce price of medicines to patients, and maintain margins for inventors and manufacturers Disposables have a key role to play as a platform technology: Driving out cost in biologics manufacturing Reducing complexity Rapid expansion & contraction of capacity Many challenges remain for disposables: Supply chain security Manufacturing standards and capacity Varying quality standards Disposable system standardization Slide 15 PharmOut 2017
16 Conclusions- a structured apprach Single-use technology analysis and feasibility assessments Rapidly changing area need to keep current Identify the added value technologies Fully" disposable manufacturing plant design Use the appropriate amount don't go fully disposable for disposables sake Use structured evaluation methodology Cost Technologies Design options Vendor Supply chain security Integrated disposable and stainless steel manufacturing plant design Slide 16 PharmOut 2017
17 Thank you for your time. Questions? Gordon Farquharson Executive Consultant Slide 17 PharmOut 2017
Advancements on implementation of single use technology in vaccine manufacturing
Advancements on implementation of single use technology in vaccine manufacturing October 25 th, 2013 DCVMN Meeting Rio de Janeiro, Brazil Outline Overview of single use products Applications of single
More informationSingle-Use Final Fill: Benefits and Considerations
Single-Use Final Fill: Benefits and Considerations TENDÊNCIAS DE TECNOLOGIAS DE FABRICAÇÃO E ASSÉPTICA DE MEDICAMENTOS Ana Luísa Lampert Cadore Sales Specialist SU & Aseptic Process Solutions ana.cadore@merckgroup.com
More informationDisposable Technology - a technobusiness perspective
Disposable Technology - a technobusiness perspective A Business Briefing being held on 10th March 2011 With Mrs Miriam Monge, VP Marketing Biopharm Services, Chairs: Prof Gary Lye and Prof Eli Keshavarz-Moore,
More informationNew Product Brief PreVAS Single-use Dosing System. Packaging Technology. 3 Disposable Dosing Systems
3 Disposable Dosing Systems New Product Brief PreVAS Single-use Dosing System Packaging Technology Copyright 2010 Bosch Packaging Technology. PreVAS Brochure V3 7-2010. Subject to change without notice.
More informationAcerta Disposable Filling System
Acerta Disposable Filling System The Evolution of a New Disposable Filling Technology for Sterile Pharmaceuticals Presented May 4, 2004 By Jim Furey, Product Manager Millipore Corporation Innovative Enabling
More informationHow single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs
WHITE PAPER 7004 How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs By John Boehm Business Unit Manager Colder Products Company Today s
More informationGuiding Principles for the implementation of fluid management technologies for modern single use aseptic processing
Guiding Principles for the implementation of fluid management technologies for modern single use aseptic processing Jean-Marc Cappia, Vice President Marketing Fluid Management Technologies Agenda 1. Aseptic
More informationApplication of Disposable Technologies in Biopharmaceutical Manufacturing
BMD Summit, Disposables for Biopharm Production 13th December 2005 Reston, VA, USA Application of Disposable Technologies in Biopharmaceutical Manufacturing Martin Wrankmore, Continuous Improvement Lead,
More informationDriving Value through Innovation in Biotech Manufacturing. Agenda
Driving Value through Innovation in Biotech Manufacturing Jorg Thommes, PhD Senior Vice President Operations Technology and Innovation Biogen 7 October 2015 Agenda Biopharma Legacy, Trends, & Challenges
More informationMasterflex Tubing Formulations
Masterflex Tubing Formulations Platinum-Cured Silicone Tubing Specifications: Biocompatible Moderate lifetime Moderate spallation Moderate pressure Moderate gas permeability Translucent Dynamic temperature
More informationApplying Single-Use Efficiencies to Room-to-Room Fluid Transfer. by Tony Butler, ASQ CSSBB Manager, Single-Use Systems AdvantaPure
Applying Single-Use Efficiencies to Room-to-Room Fluid Transfer by Tony Butler, ASQ CSSBB Manager, Single-Use Systems AdvantaPure The Challenge For biopharma manufacturers the challenge is clear: quickly
More informationConsiderations for Implementation of Single-Use Technologies in Bioprocessing. Guido Kremer-van der Kamp Merck Millipore
Considerations for Implementation of Single-Use Technologies in Bioprocessing Guido Kremer-van der Kamp Merck Millipore Single-Use Technologies in Bioprocessing Adoption of single-use technologies in biopharmaceutical
More informationEnhancing Upstream and Downstream Process Methods Through Implementation of Single-Use Technologies. 06 February 2018
Enhancing Upstream and Downstream Process Methods Through Implementation of Single-Use Technologies 06 February 2018 Overview Single-use technology (SUT) is a rapidly evolving technology that focuses on
More informationVetter Commercial Manufacturing
A unique blend of capabilities for aseptic fill and finish Vetter Commercial Manufacturing Delivering results across the production chain Answers that work 1 Manufacturing quality is just the beginning.
More information2009 INVESTOR DAY. BioPharmaceuticals. Ken Frank President BioPharmaceuticals December 17, Sustainable, Profitable Growth
2009 INVESTOR DAY BioPharmaceuticals Ken Frank President BioPharmaceuticals December 17, 2009 Sustainable, Profitable Growth Life Sciences FY 2009 Total Sales $2,329.2 (amounts shown in millions) BioPharmaceuticals
More informationFabric & Finishes. Gordon Farquharson July 2017
Fabric & Finishes Gordon Farquharson July 2017 Every Cleanroom is a Prototype!! Process & Product has unique features The building and its environment are unique The equipment configuration is unique The
More informationSingle-use technology and sustainability: quantifying the environmental impact
Single-use technology and sustainability: quantifying the environmental impact Bill Flanagan Director, Ecoassessment Center of Excellence, GE 1 November 2016 Imagination at work Agenda Biopharmaceutical
More informationEvolve with flexibility
GE Healthcare Evolve with flexibility Single-use bioprocessing Biomanufacturing: an evolving industry The biopharmaceuticals landscape is undergoing unprecedented change. As more and more biologics go
More informationGMP considerations when designing an API plant. Presented by Cameron Roberts, Senior Engineer 4 July, 2016
GMP considerations when designing an API plant Presented by Cameron Roberts, Senior Engineer 4 July, 2016 Introduction API manufacturing is too broad a topic to cover all scenarios so I will draw from
More informationApplication of Single-Use Equipment for Buffer Storage and Distribution in Medium Size mab Production Facility
Reprinted from PHARMACEUTICAL ENGINEERING THE OFFICIAL TECHNICAL MAGAZINE OF ISPE JANUARY/FEBRUARY 2014, VOL 34, NO 1 Copyright ISPE 2014 www.pharmaceuticalengineering.org facilities and equipment Application
More informationBiotech Pharmaceutical Cosmeceutical Food. Modular System Design Valves, Pumps, Fittings Heat Exchangers
Biotech Pharmaceutical Cosmeceutical Food Modular System Design Valves, Pumps, Fittings Heat Exchangers CIP Systems Bio Waste Kill Systems Purification Systems Utility Process Modules Formulation Systems
More informationA Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.
A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody. Jeremy M Tong (presenting), Mark S Kettel, Edward M Perry, David J Pain, David M Valentine,
More informationSingle-use technology in downstream unit operations
Single-use technology in downstream unit operations ÄKTA ready chromatography system and more Madhu Raghunathan, Bioprocess capability days, Boston Imagination at work Presentation outline Introduction
More informationVetter Development Service
A unique blend of expertise for clinical manufacturing Vetter Development Service Supporting your compound s success Answers that work 1 Your molecule s future starts here. By the time your new injectable
More informationFlexsafe 2D & 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future
& 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future 2 & 3D Pre-designed Solutions Table of Contents Please click on headline to go to the selected page Back Go to to
More informationThe Opta SFT-D is available as individual device for end-user assembly with TPE tubing and autoclave sterilization.
Fluid Management 259 Connections 260 Flexboy Bags 264 Flexel 3D Bags 276 Palletank 304 Instruments 314 Single-Use Mixing 318 Freeze-Thaw Systems 354 Aseptic Transfer System 380 Configurable Solutions FlexAct
More informationInnovative. to the pharmaceutical, biotechnology and advanced technology. and equipment. Our learning management
Innovative S o l u t i o n s Pharma-Tech Process and Facilities Services is an industry leader in providing innovative technical consulting and staff-augmentation services to the pharmaceutical, biotechnology
More informationFlexsafe 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future
Flexsafe 3D Pre-Designed Solutions for Storage and Shipping Take Your Facility Into The Future 2 Flexsafe 3D Pre-designed Solutions Table Please click on headline to go to the selected page Digital Selection
More informationContinental Disc Corporation
Continental Disc Corporation Founded in 1965 (almost 50 years experience) Global leader in Rupture Disc Manufacturing We have the Best Rupture Disc in the market!!! Why Rupture Discs? Safeguard against
More informationCAPITAL COST ESTIMATING. 23 rd Jan 2017
CAPITAL COST ESTIMATING 23 rd Jan 2017 ESTIMATING PLANT CAPITAL COST (Projects Financial Viability) SO FAR (?):- Project has a defined technical solution Flow Sheeting NOW (?):- What is the cost of the
More informationCSL s Large Scale Cell Culture Facility
BioProcess Network 20 th October 2011 CSL s Large Scale Cell Culture Facility Tim Hughes Sr. Dir. Clinical Manufacturing CSL Objective How to maximise the opportunity to build a state-of-theart facility
More informationVetter Development Service
A unique blend of expertise for clinical manufacturing Vetter Development Service Supporting your compound s success Answers that work 1 Your molecule s future starts here. By the time your new injectable
More informationFlexboy 2D Pre-designed Solutions for Storage Best Performance, Assurance of Supply and Closure Integrity for All Process Steps
Storage Best Performance, Assurance of Supply and Closure Integrity for All Process Steps 2 Flexboy 2D Pre-designed Solutions Table Please click on the headline to go to the selected topic Digital Selection
More informationProcess economic simulation for scalable production of adenovirus
Process economic simulation for scalable production of adenovirus This application note discloses process economic modelling of a modern start-to-finish adenovirus production process. The novel process
More informationGlobal Sterile Liquid Capabilities
Global Sterile Liquid Capabilities The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. WHY US? Our Global Sterile Liquid capabilities are designed to enhance and streamline
More informationDesign Considerations for TGA Licensed Pharmacies. Presented by Ashley Isbel 11 th August 2015
Design Considerations for TGA Licensed Pharmacies Presented by Ashley Isbel 11 th August 2015 Focus of the session Primarily of relevance to sterile compounding facilities, particularly those producing
More informationSingle Use Bioreactor Scale up: Introduction of a 2000L SUB Equipment Train in 12 months
Single Use Bioreactor Scale up: Introduction of a 2000L SUB Equipment Train in 12 months Finesse CellWorld San Fransisco Claire Walsh BSc, MSc BioProcess Skills and Technology, Operations, Janssen Sciences
More informationIntensification of a Perfusion Platform using Single-use XCell ATF Systems
Intensification of a Perfusion Platform using Single-use XCell ATF Systems Olaf Mol Sr. Bioprocess Scientist The world leader in serving science Global Footprint- Biologics Princeton, USA PD Center of
More informationFlexsafe 3D Pre-Designed Solutions for Storage and Shipping Consistent Performance and Best Assurance of Supply for All Process Steps
Flexsafe 3D Pre-Designed Solutions for Storage and Shipping Consistent Performance and Best Assurance of Supply for All Process Steps Flexsafe 3D Pre-designed Solutions Table Please click on headline to
More informationTAKEONE Aseptic Sampling System
TAKEONE Aseptic Sampling System What would you do if...you had more time? Break Bottlenecks The patented TAKEONE aseptic sampling system is the only system of its kind. TAKEONE is delivered fully assembled
More informationRecent Developments & Future Directions in the Production of Monoclonal Antibodies. Rob Noel Plasma Product Biotechnology Conference 2009, Menorca
Recent Developments & Future Directions in the Production of Monoclonal Antibodies Rob Noel Plasma Product Biotechnology Conference 2009, Menorca Forecast sales by molecule type ($m), 2006 12 600,000 Pharmaceuticals
More informationSafer, easier and faster drug delivery Weibel CDS AG develops and produces innovative, user friendly, application oriented Injections Systems and
Safer, easier and faster drug delivery Weibel CDS AG develops and produces innovative, user friendly, application oriented Injections Systems and Devices. upgrades your vial practically to a syringe Vials
More informationValidation Needs for Sterilization by Aseptic Filtration
Validation Needs for Sterilization by Aseptic Filtration DCVMN Workshop, Hyderabad, 4-8 April 2016 Ramesh Raju Associate Director - Provantage Validation Services Overview Key Regulatory and Industry guidelines
More informationShow Me the Green! A Value Plastics White Paper
Value Plastics, inc. SPECIALISTS IN FLUID CONNECTIONS TM Single-Use Systems Show Me the Green! A Value Plastics White Paper Value Plastics, inc. SPECIALISTS IN FLUID CONNECTIONS TM Single-Use Systems Show
More informationJM BioConnect - Make the Connection
JM BioConnect - Make the Connection JM BioConnect s mission statement is to be the upstream and downstream disposable process solution specialist based on open architecture. This is not limited to single
More informationNew technologies in biopharmaceutical processes BioTech Vaccines Plasma
New technologies in biopharmaceutical processes BioTech Vaccines Plasma Dominik Arnold dominik_arnold@pall.com Challenges in Down Stream Processing Higher. Titers >4 g/l Yield > 90% Protein concentration
More informationPerformance Beyond Expectation. Tanks& Mixing
Performance Beyond Expectation Tanks& Mixing Creative Mixing Solutions MGT Liquid and Process Systems specializes in designing and manufacturing of custom-made, innovative stainless steel process solutions
More informationA Journey in Global PUPSIT Implementation with Benchmarking. PDA Midwest Event Oct 5th, 2017 Jeff Gaerke P.E.
A Journey in Global PUPSIT Implementation with Benchmarking PDA Midwest Event Oct 5th, 2017 Jeff Gaerke P.E. Purpose Share learning on ongoing global implementation of PUPSIT for parenteral operations.
More informationEnvironmental Services Conference
Sharps Compliance Corp. NASDAQ: SMED Credit Suisse Industrial and Environmental Services Conference May 24, 2011 Diana P. Diaz Vice President and Chief Financial Officer 1 Safe Harbor Statement These slides
More informationTom Sulpizio and Jeff Taniguchi, Advanced Minerals Corporation A Member of Imerys 130 Castilian Way, Santa Barbara, CA 93117
ADVANCES IN DISPOSABLE DIATOMITE FILTER AID SYSTEMS FOR CGMP BIOSEPARATIONS Session Pretreatment in Bioseparations AFSS Annual Meeting Valley Forge, PA May 20, 2008 ABSTRACT Tom Sulpizio and Jeff Taniguchi,
More informationThe Use of BPOG Generated Extractables Data for Toxicological Assessment
The Use of BPOG Generated Extractables Data for Toxicological Assessment Sade Mokuolu, Ph.D Group Product Compliance Manager, WMFTG PDA Brazil 2017 Disclaimer This presentation is the copyright information
More informationSINGLE USE SYSTEMS KEY FEATURES FOR PHARMACEUTICAL & BIOTECH PROCESSING APPLICATIONS TECH SHEET
SINGLE USE SYSTEMS FOR PHARMACEUTICAL & BIOTECH PROCESSING APPLICATIONS Eliminate production stoppages for sterilization, reduce the risk of contamination, and increase efficiency by incorporating single
More informationXDR Single-Use Bioreactors
DATA SHEET XDR Single-Use Bioreactors Introduction The XDR Single-Use Bioreactor is a fully-integrated system that delivers proven stirred-tank performance across a wide range of cell lines. Single use
More informationSterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM
Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory
More informationKeeping up with Single-Use Geoffrey Hodge SVP Operations Unum Therapeutics 07 Oct 15
Keeping up with Single-Use Geoffrey Hodge SVP Operations Unum Therapeutics 07 Oct 15 Outline Introduction / Overview Technology Survey Economics Quality Single Use Facilities Summary 1 Introduction Disclaimer
More informationContract Manufacturing Services for Pre-filled Syringes
Contract Manufacturing Services for Pre-filled Syringes From Standard Solutions to Complex Products Stefan Czvitkovich, PhD Director Product Partnering Sterile Pharmaceuticals Central Europe CPhI woldwide
More informationF3 50/500 PILOT AND SMALL INDUSTRIAL PRODUCTION SIP BIOREACTORS/FERMENTORS
F3 50/500 PILOT AND SMALL INDUSTRIAL PRODUCTION SIP BIOREACTORS/FERMENTORS THE COMPANY Bionet is a specialist in bioprocesses engineering. We provide equipment (Bioreactors, Cross-Flow Filtration Systems
More informationCompliance Workshop for Regulated Mobile Applications
Compliance Workshop for Regulated Mobile Applications Presented by Seamus Orr 11 August 2015 150403_POUT Agenda Introduction Practical examples of regulated or GxP mobile applications? Risk/Benefit Case
More informationFILTRODISC BIO SD State of the art Midstream microfiltration e.g. for cell removal
FILTRODISC BIO SD State of the art Midstream microfiltration e.g. for cell removal MICROFILTRATION FOR VALUABLE LIQUIDS. St. Gallen, March 1st, 2018, GMS The FILTROX Group The FILTROX Group is an international
More informationContinuous Processing Progress in Manufacturing
Cell World Conference, San Francisco, May 25-26 2017 Dr. Berthold Boedeker, Bayer AG, Biological Development Biologics at Bayer Regulatory support / drivers aof continuous processing Bayer s approach to
More informationCARR ViaFuge Technology
CARR ViaFuge Technology CARR ViaFuge Based on proven Powerfuge technology Scalable solution TrueClean TM design new SoftStream TM feed design Enabling Cell Harvest Technology Recovery of viable, intact
More informationThermo Scientific HyClone Single-Use Bioreactor Products and Capabilities. Discovery Development Production
Thermo Scientific HyClone Single-Use Bioreactor Products and Capabilities Discovery Development Production Introduction Leading the way in Single-Use Bioreactors Since its introduction, the Thermo Scientific
More informationAgenda. Pharma EXPO 6 9 November 2016 Chicago, IL FLEXIBLE FACILITIES THE BENEFITS OF MODULAR AND PREFABRICATED CLEANROOM STRUCTURES
FLEXIBLE FACILITIES THE BENEFITS OF MODULAR AND PREFABRICATED CLEANROOM STRUCTURES Maik W. Jornitz President G-CON Manufacturing Inc. Agenda Hot Button Headlines Future Needs The Past does not Fit The
More informationSafe Harbor Statement
Safe Harbor Statement Sharps Compliance, Inc. Noble Financial Sixth Annual Equity Conference June 8, 2010 Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain)
More informationSCHOTT Pharmaceutical Systems. adaptiq - ready-to-use vials for aseptic processing
SCHOTT Pharmaceutical Systems adaptiq - ready-to-use vials for aseptic processing Todays market trends require flexible filling concepts and pre sterilized (RTU) containers Targeted medicine e.g. Oncology
More informationContinuously Improving Bioprocesses: Biopharmaceutical Capabilities
Continuously Improving Bioprocesses: Biopharmaceutical Capabilities Pall Corporation A Legacy of Innovation Dr. David B. Pall Founded by Dr. David B. Pall in 1946, Pall Corporation has grown from a company
More informationImplementation of a Micro Bioreactor System for Platform Cell Culture Process Development at Cobra Biologics
Implementation of a Micro Bioreactor System for Platform Cell Culture Process Development at Cobra Biologics Kristina Lae, Scientist, Cell Culture Cobra Biologics, Södertälje, Sweden Cobra Biologics and
More informationThe biopharmaceutical industry
S i n g l e - U s e APPLICATIONS Understanding Particulates in Single-Use Bags Their Relationship to USP Chapter by Michael W. Johnson The biopharmaceutical industry is facing many challenges. Global
More informationSINGLE-USE MOLDED MANIFOLDS FOR PRODUCT SAMPLING & STORAGE APPLICATIONS
Single-Use Molded Manifolds are custom made to meet your product sampling and storage needs in drug and vaccine production. Manufactured from AdvantaFlex biopharmaceutical grade TPE or platinum-cured Class
More informationSA 450/65 Material Data Sheet
General Product Information SA 450/65 Material Data Sheet SA 450/65 is a speciality medical grade platinum cured elastomer, offering high clarity combined with excellent physical properties with a dry
More informationThe Green, Clean and Lean Approach to Cleaning API Equipment
The Green, Clean and Lean Approach to Cleaning API Equipment By: Albin J. Friedrich Project Manager - Mork Process Inc. Traditional Clean-in-Place (CIP) technology has its shortcomings: its labor intensive,
More informationDPTE -EN 1 DPTE TRANSFER SYSTEM THE GLOBAL REFERENCE
DPTE -EN 1 DPTE TRANSFER SYSTEM THE GLOBAL REFERENCE 2 DPTE -EN GETINGE-LA CALHÈNE DPTE SYSTEM A CLEVER TRANSFER SYSTEM The DPTE transfer system enables the user to introduce material into, or to extract
More informationCOMPONENTS A full range of peripherals, accessories, probes and measuring systems and components is offered for bioreactors & fermenters.
BIOREACTORS & FERMENTERS Classical stirred tank bioreactors & fermenters suitable for microbial, yeast, algae, plant and animal cells are offered in all sizes from laboratory to production. Either as stand
More informationSafe Harbor Statement
Safe Harbor Statement Sharps Compliance Corp. NASDAQ: SMED Barrington Consumer & Business Services Conference December 9, 2010 David P. Tusa Chief Executive Officer and President Diana P. Diaz Chief Financial
More informationUnderstanding modular automation
Understanding modular automation Answers to the most commonly asked questions for those entering the world of modular automation Large-scale automation systems have been at the heart of production line
More informationQuality & Regulatory Issues in Biopharmaceutical Facility Design A Perspective from Industry Trends
Quality & Regulatory Issues in Biopharmaceutical Facility Design A Perspective from Industry Trends Paul Smock, Biotechnology Quality & Technical Consultant Meridian BioGroup LLC The opinions and views
More informationBiopharmaceutical Multi-Product Facilities: the Challenges and the Solutions. Frank Hallinan EBE Biopharmaceutical Manufacturing & CMC Conference
Biopharmaceutical Multi-Product Facilities: the Challenges and the Solutions. Frank Hallinan EBE Biopharmaceutical Manufacturing & CMC Conference Barcelona, March 21, 2011 Agenda: The Past The Business
More informationSingle-Use Products in BioManufacturing: Innovations Driving the Industry Bioprocess International SUPPLEMENT March 2011 By Eric Langer
Single-Use Products in BioManufacturing: Innovations Driving the Industry Bioprocess International SUPPLEMENT March 2011 By Eric Langer Biopharmaceutical manufacturers and CMOs are continuing to integrate
More informationBioprocessing Challenges: High-Titer Mammalian-Based Cell Systems. Elements influencing the way Biologics may be manufactured /supplied in the future
Bioprocessing Challenges: High-Titer Mammalian-Based Cell Systems Jonathan Romero CMC Leadership, Technical Development Pharmaceutical Operations & Technology 2015 ISPE PRODUCT SHOW Business Drivers Elements
More informationPHARMA / BIOTECH AGITATOR TECHNOLOGY IN PERFECTION
PHARMA / BIOTECH AGITATOR TECHNOLOGY IN PERFECTION High level consulting from the very beginning of a project EXCELLENT QUALITY, FIRST-CLASS ADVICE: THE PERFECT MIX FOR YOUR SUCCESS With more than 35 years
More informationCritical Analytical Measurements for Bioreactor Optimization. controlling an organism s chemical environment leads to consistent and
Critical Analytical Measurements for Bioreactor Optimization Mettler-Toledo Ingold, Inc., Bedford, MA Abstract Most bioreactor processes share a basic principle; optimizing and controlling an organism
More informationOperational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production
UCL Decisional Tools Research Operational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production Suzanne Farid PhD CEng FIChemE Reader (Associate
More informationPurposeful design of a next-generation single-use film for optimized performance in biomanufacturing
Purposeful design of a next-generation single-use film for optimized performance in biomanufacturing Susan Burke, PhD Bioprocess R&D GE Healthcare, Life Sciences Overview Complex demands on bioprocess
More informationF2 15/30 SIP PILOT SCALE BIOREACTORS
F2 15/30 SIP PILOT SCALE BIOREACTORS THE COMPANY Bionet is a specialist in bioprocesses engineering. We provide equipment (Bioreactors, Cross-Flow Filtration Systems and Cleaning-In-Place Systems) and
More informationStandard Flexel 3D bioprocessing bags for Palletank (For Europe, Asia and Latin America)
Standard Flexel 3D bioprocessing bags for Palletank (For Europe, Asia and Latin America) Fluid Management Systems Features Multiple manufacturing sites All connections extensively qualified Full compliance
More informationBIO-WASTE SYSTEMS. Thermal & Chemical Effluent Kill Systems. Biotech & Pharmaceutical. Batch Process Systems. Continuous Process Systems
Biotech & Pharmaceutical BIO-WASTE SYSTEMS Thermal & Chemical Effluent Kill Systems Batch Process Systems Continuous Process Systems Sump Collection Systems Heat Inactivation Chemical Inactivation Neutralization
More informationFlexel Pre-designed Solutions for Mixing Intelligent, Powerful and Intuitive Mixing for your cgmp Biomanufacturing
Flexel Pre-designed Solutions for Mixing, Powerful and Intuitive Mixing for your cgmp Biomanufacturing Flexel Mixer Pre-designed Solutions Table Please click on the headline to go to the selected topic
More informationStandard Flexel 3D bioprocessing bags for Palletank (US and Canada)
Standard Flexel 3D bioprocessing bags for Palletank (US and Canada) Fluid Management Systems Features Multiple manufacturing sites All connections extensively qualified Full compliance with ISO37 Standard
More informationValidation. An Easy to Understand Guide Validating Purified Water Systems
Validation Overview Validation Documentation Validation Activities Validation Mistakes Validation Protocols Test Selection Common Verifications When to test Test Layout and Content Validation Protocol
More informationHuman Microbiota: proof of concept to production. Michael van der Horst Process Engineer Technical Operations SynCo Bio Partners B.V.
Human Microbiota: proof of concept to production Michael van der Horst Process Engineer Technical Operations SynCo Bio Partners B.V. SynCo Bio Partners B.V. Who we are and what we do Licensed cgmp CMO
More informationCleaning Validation PRODUCT OVERVIEW
PRODUCT OVERVIEW E700 SERIES SUCCESS IN PHARMA Prozess has established itself as a leader in the technically challenging and regulatory complex pharmaceutical sector, and includes 16 of the top 20 global
More informationFuture biologics manufacturing
Future biologics manufacturing Process integration with single-use technology Dr. Günter Jagschies Senior Director, Strategic Customer Relations GE Healthcare Life Sciences Uppsala, Sweden Mammalian Cell
More informationH-Class & H-Class Bio AutoBlend and AutoBlend plus. Jean-Michel Plankeele May Waters Corporation 1
H-Class & H-Class Bio AutoBlend and AutoBlend plus Jean-Michel Plankeele May 2012 2012 Waters Corporation 1 UPLC H-Class Introduction in 2010 What Were The Requests? More flexibility? More solvent capability
More informationWhitepaper. Small Molecule Vs Cell Therapy Clinical Trial Supply Chain. Martin Lamb, Executive Vice President for Sales and Marketing
Small Molecule Vs Cell Therapy Clinical Trial Supply Chain Page 1 Whitepaper Small Molecule Vs Cell Therapy Clinical Trial Supply Chain Martin Lamb, Executive Vice President for Sales and Marketing Small
More information未来已来! 战略供应链的时代已来临 : 未来竞争制胜的运营模式
2012 中国供应链高峰会议 China Supply Chain Executive Summit 未来已来! 战略供应链的时代已来临 : 未来竞争制胜的运营模式 The Strategic Supply Chain: An Operating Model Whose Time Has Come 柯磊先生 Mr. Craig Kerr 普华永道管理咨询, 合伙人 Partner, PwC Consulting
More informationF2 15/30 SIP PILOT SCALE BIOREACTORS
F2 15/30 SIP PILOT SCALE BIOREACTORS THE COMPANY Bionet is a specialist in bioprocesses engineering. We provide equipment (Bioreactors, Cross-Flow Filtration Systems and Cleaning-In-Place Systems) and
More informationStandard Scalable Flexel 3D Bioprocessing Bags
Standard Scalable Flexel 3D Bioprocessing Bags Fluid Management Systems Description Standard Scalable Flexel 3D Bioprocessing Bags are designed for processing and storage of small volume biopharmaceutical
More information,1+#$# 1)0'+!0',+!) -&!.*!"$10'"!)/ ",*-!+4 !/ %.,3+ 0.,+% *!+!%$*$+0 0$!* )2,0$"&
ALVOTECH 2017 ALVOGEN 9.5.2017 3 ALVOGEN WORLDWIDE 35 Alvogen worldwide offices BIOPHARMACEUTICALS ARE THE FUTURE Biologic molecules are the future of the pharmaceutical industry due to type of diseases
More informationThe expanding complexity of
A Vaccine Case Study Qualifying Redundant Disconnection Technologies As Container-Closure Systems for Long-Term Storage and Shipping Christine Megarity and Bobbi Allen The expanding complexity of biopharmaceutical
More information